83 related articles for article (PubMed ID: 7751011)
1. Inhibition of protein kinase C results in a switch from a non-motile to a motile phenotype in diverse human lymphocyte populations.
Southern C; Wilkinson PC; Thorp KM; Henderson LK; Nemec M; Matthews N
Immunology; 1995 Feb; 84(2):326-32. PubMed ID: 7751011
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase C isotype expression and regulation of lymphoid cell motility.
Thorp KM; Verschueren H; De Baetselier P; Southern C; Matthews N
Immunology; 1996 Mar; 87(3):434-8. PubMed ID: 8778030
[TBL] [Abstract][Full Text] [Related]
3. Selective effects of the PKC inhibitors Ro 31-8220 and CGP 41,251 on PMN locomotion, cell polarity, and pinocytosis.
Keller HU; Niggli V
J Cell Physiol; 1994 Dec; 161(3):526-36. PubMed ID: 7962133
[TBL] [Abstract][Full Text] [Related]
4. Effect of serine/threonine kinase inhibitors on motility of human lymphocytes and U937 cells.
Thorp KM; Southern C; Matthews N
Immunology; 1994 Apr; 81(4):546-50. PubMed ID: 8039806
[TBL] [Abstract][Full Text] [Related]
5. Selective responses (actin polymerization, shape changes, locomotion, pinocytosis) to the PKC inhibitor Ro 31-8220 suggest that PKC discriminately regulates functions of human blood lymphocytes.
Trachsel S; Keller HU
J Leukoc Biol; 1995 Apr; 57(4):587-91. PubMed ID: 7536787
[TBL] [Abstract][Full Text] [Related]
6. Effects of a new protein kinase C inhibitor CGP 41251 on T cell functions: inhibition of activation, growth, and target cell killing.
Alkan SS; Rutschmann S; Grogg D; Erb P
Cell Immunol; 1993 Aug; 150(1):137-48. PubMed ID: 8102085
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of chemotactic peptide-induced development of cell polarity and locomotion by the protein kinase C inhibitor CGP 41 251 in human neutrophils correlates with inhibition of protein phosphorylation.
Niggli V; Keller H
Exp Cell Res; 1993 Feb; 204(2):346-55. PubMed ID: 8440331
[TBL] [Abstract][Full Text] [Related]
8. GF109203X, a specific PKC inhibitor, abrogates anti-CD3 antibody-induced upregulation of CD4+ T cell adhesion to B cells.
Hauss P; Mazerolles F; Hivroz C; Lecomte O; Barbat C; Fischer A
Cell Immunol; 1993 Sep; 150(2):439-46. PubMed ID: 8103710
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an alpha-, beta-, and zeta-protein kinase C-independent pathway.
Jalava A; Akerman K; Heikkilä J
J Cell Physiol; 1993 May; 155(2):301-12. PubMed ID: 8482723
[TBL] [Abstract][Full Text] [Related]
10. Effect of a selective protein kinase C inhibitor, Ro 31-8425, on Mac-1 expression and adhesion of human neutrophils.
Sullivan JA; Merritt JE; Budd JM; Booth RF; Hallam TJ
Eur J Immunol; 1994 Mar; 24(3):621-6. PubMed ID: 8125132
[TBL] [Abstract][Full Text] [Related]
11. Regulation by phorbol ester and protein kinase C inhibitors, and by a protein phosphatase inhibitor (okadaic acid), of P-glycoprotein phosphorylation and relationship to drug accumulation in multidrug-resistant human KB cells.
Chambers TC; Zheng B; Kuo JF
Mol Pharmacol; 1992 Jun; 41(6):1008-15. PubMed ID: 1377325
[TBL] [Abstract][Full Text] [Related]
12. Sublethal levels of oxidant stress stimulate multiple serine/threonine kinases and suppress protein phosphatases in Jurkat T cells.
Whisler RL; Goyette MA; Grants IS; Newhouse YG
Arch Biochem Biophys; 1995 May; 319(1):23-35. PubMed ID: 7771789
[TBL] [Abstract][Full Text] [Related]
13. Differential modulation of human fibroblast and keratinocyte growth by the protein kinase C inhibitor GF 109203X.
Le Panse R; Coulomb B; Mitev V; Bouchard B; Lebreton C; Dubertret L
Mol Pharmacol; 1994 Sep; 46(3):445-51. PubMed ID: 7935324
[TBL] [Abstract][Full Text] [Related]
14. Definition of early Ca2+ signals induced by anti-CD3 antibody in a human Jurkat T-cell line using a selective protein kinase C inhibitor, Ro 31-8425.
Conroy LA; Merritt JE; Giafi CF; Lamont AG; Hallam TJ
Biochem Soc Trans; 1993 Nov; 21(4):384S. PubMed ID: 8131961
[No Abstract] [Full Text] [Related]
15. Modulation of human basophil histamine release by protein kinase C inhibitors differs with secretagogue and with inhibitor.
Bergstrand H; Lundquist B; Karabelas K; Michelsen P
J Pharmacol Exp Ther; 1992 Mar; 260(3):1028-37. PubMed ID: 1372047
[TBL] [Abstract][Full Text] [Related]
16. PMA inhibits the growth of human fibroblasts after the induction of immediate-early genes.
Bi N; Mamrack MD
Exp Cell Res; 1994 May; 212(1):105-12. PubMed ID: 8174632
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of signal transduction mechanisms in human basophils and human skin mast cells. II. Effects of 7-O-methyl-UCN-01, NPC 15437 and bryostatin 1 and 2, four protein kinase C-modulatory agents, on mediator release.
Noll T; Dieckmann D; Gibbs BF; Nitschke M; Albrecht C; Vollrath I; Tamaoki T; Wolff HH; Amon U
Biol Signals; 1997; 6(1):1-10. PubMed ID: 9098518
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase C and mammary cell differentiation: involvement of protein kinase C alpha in the induction of beta-casein expression.
Marte BM; Meyer T; Stabel S; Standke GJ; Jaken S; Fabbro D; Hynes NE
Cell Growth Differ; 1994 Mar; 5(3):239-47. PubMed ID: 8018556
[TBL] [Abstract][Full Text] [Related]
19. The selective protein kinase C inhibitor GF 109203X inhibits phorbol ester-induced morphological and functional differentiation of SH-SY5Y human neuroblastoma cells.
Heikkilä J; Jalava A; Eriksson K
Biochem Biophys Res Commun; 1993 Dec; 197(3):1185-93. PubMed ID: 8280132
[TBL] [Abstract][Full Text] [Related]
20. The role of protein kinase C in the regulation of extracellular signal-regulated kinase by the T cell antigen receptor.
Izquierdo M; Leevers SJ; Williams DH; Marshall CJ; Weiss A; Cantrell D
Eur J Immunol; 1994 Oct; 24(10):2462-8. PubMed ID: 7925576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
